Did you miss the live webinar? Don't worry it's now available on-demand. Join us for an insightful discussion aimed at delving into how employers are tackling the intricate challenges posed by rising healthcare costs while prioritizing employee health and well-being.
The FDA had asked Biogen and Sage Therapeutics to provide more clinical data supporting Zurzuvae in major depressive disorder. Citing the time and expense of additional clinical trials, the partners decided against further development in this indication
Most Americans don't understand how an administration's view on healthcare data sharing interoperability could directly impact them, pointed out Arcadia CEO Michael Meucci. More requirements around data sharing could lead to better care continuity, improved outcomes and lower costs.
The status quo is simply untenable for many companies as health insurance costs spiral. From family-owned businesses to large enterprises, employers are taking advantage of an alternative designed by politicians on both sides of the aisle.
Truth is, there are hugely positive tailwinds at our back. But the way we've been thinking about the problem is holding us back from solving it. Here's why.
The shifting AI landscape. Learn about the emerging technologies from AI tech developers across the healthcare landscape from health tech startups to healthcare organizations, biopharma companies, and a medtech giant.
No comments